title: Implementing a policy for pneumococcal prophylaxis in a haematology unit after splenectomy.
abstract: People who have had a splenectomy for any reason are 40 times more likely to have an overwhelming infection, especially pneumococcal infection, and 17 times more likely to suffer fatal sepsis. The incidence of such life threatening infections is reduced by prophylactic immunisation with polyvalent pneumococcal vaccine and long term antibiotic prophylaxis or instituting prompt antibiotic treatment in the event of fever. This haematology unit agreed a policy of immunisation and antibiotic prophylaxis in June 1988 for all patients undergoing elective splenectomy. The success of this policy was audited in July 1993 by a retrospective analysis of patients' case notes. Seventy four patients were identified as having had a splenectomy, 54 (73%) before June 1988, of whom only 13 (24%) had received both pneumococcal immunisation and antibiotic prophylaxis before implementation of the agreed policy. At the time of audit, 46/74 (62%) patients were recorded as having received immunisation and 64/74 (86%) as receiving antibiotic prophylaxis or a supply of antibiotics to take in the event of a fever. All but one of the 20 patients who had a splenectomy after June 1988, since implementation of the agreed policy, received immunisation and antibiotic prophylaxis. The authors conclude that establishment of a formal agreed policy for pneumococcal prophylaxis for patients undergoing splenectomy has improved the quality of care.
authors.affiliation: Birmingham Heartlands Hospital, England.
authors.forename: S G
authors.initials: SG
authors.lastname: Long
authors.forename: A G
authors.initials: AG
authors.lastname: Smith
authors.forename: B A
authors.initials: BA
authors.lastname: Perry
authors.forename: M J
authors.initials: MJ
authors.lastname: Leyland
authors.forename: D W
authors.initials: DW
authors.lastname: Milligan
mesh_terms: D019072:Antibiotic Prophylaxis / Q000592:standards*; D001428:Bacterial Vaccines / Q000627:therapeutic use*; D004198:Disease Susceptibility / Q000276:immunology; D006757:Hospital Units / Q000592:standards*; D006801:Humans; D008131:London; D016134:Organizational Policy; D011008:Pneumococcal Infections / Q000517:prevention & control*; D011183:Postoperative Complications / Q000517:prevention & control*; D017410:Practice Guidelines as Topic; D013156:Splenectomy / Q000009:adverse effects*